Results 11 to 20 of about 48,270 (163)

Reticular telangiectatic erythema: case report and literature review

Dermatology Practical & Conceptual, 2015
Background: Reticular telangiectatic erythema is a benign cutaneous reaction that may occur in patients who have received a subcutaneous implantable cardioverter-defibrillator.
Bryce D. Buetler, Philip R. Cohen
doaj   +1 more source

Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis [PDF]

, 2017
Objective: The recent Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) trial suggested that implantable cardioverter defibrillators (ICDs) do not reduce overall mortality in patients ...
Beggs, Simon A.S., Gardner, Roy S., Jackson, Colette E., Jhund, Pardeep S., McMurray, John J.V.   +4 more
core   +1 more source

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Among patients with an implantable cardioverter‐defibrillator, a high prevalence of atrial fibrillation (AF) is present. Identification of AF predictors in this patient group is of clinical importance to initiate appropriate preventive ...
Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Nikki van Pouderoijen, Judith Krabbenborg, Mark J. Mulder, Mischa T. Rijnierse, Pranav Bhagirath, Lourens F. H. J. Robbers, Albert C. van Rossum, Vokko P. van Halm, Marco J. W. Götte, Cornelis P. Allaart   +11 more
doaj   +1 more source

Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study

SAGE Open Medicine, 2016
Background: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients.
Jane MacIver, Alana Tibbles, Filio Billia, Heather Ross   +3 more
doaj   +1 more source

Irradiation treatment of laryngeal cancer in a patient with an implantable cardioverter-defibrillator (ICD) [PDF]

, 2007
Background: Due to an aging population the incidence of both cardiac and tumor-related illnesses is increasing. A problem may arise if radiotherapy is necessary in close anatomic proximity to an implantable cardioverter-defibrillator (ICD).
Krimmel, Klaus, Schaffer, Moshe, Schaffer, Pamela Manuela, Sepe, Susanna   +3 more
core   +1 more source

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator [PDF]

, 2018
The trans-venous implantable cardioverter defibrillator (TV-ICD) is effective in treating life-threatening ventricular arrhythmia and reduces mortality in high-risk patients.
Adduci, Carmen, Francia, Pietro, Palano, Francesca   +2 more
core   +2 more sources

Selecting patients with nonischemic dilated cardiomyopathy for ICDs [PDF]

, 2017
No abstract ...
Cleland, John G.F., Halliday, Brian P., Prasad, Sanjay K.   +2 more
core   +1 more source

Implantable Cardioverter Defibrillator

Majalah Kardiologi Indonesia, 2013
Ide penggunaan Implantable Cardioverter Defibrillator (ICD) untuk pencegahan kematian jantung mendadak pertama kali dicetuskan oleh Dr. Michel Mirowski pada tahun 1970. Sejak itu ICD berkembang dari sebuah prototipe yang dicoba pada binatang menjadi alat
Dicky Armen Hanafy
doaj   +1 more source

Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes [PDF]

, 2011
We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator ...
Jason Bradfield, Roderick Tung, Noel G. Boyle, Kalyanam Shivkumar   +3 more
core   +1 more source

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source